Please assess the completion status of the following clinical trial:

Trial Title: Combined Letrozole and Clomid in Women With Infertility and PCOS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Willing to comply with all study procedures and be available for the duration of the study~2. Diagnosis of infertility: Inability of couple to achieve successful pregnancy after 12 months of regular timed unprotected intercourse in women less than 35 years of age; and after 6 months of regular intercourse without use of contraception in women 35 years and older~3. Diagnosis of polycystic ovary syndrome based on Revised Rotterdam criteria~4. Ability to have regular intercourse during the ovulation induction phase of the study~5. Normal sperm concentration of 15 million/mL and with normal motility of \> 40% according to World Health Organization cutoff points, in at least one ejaculate during the previous year~Exclusion Criteria:~1. Current pregnancy~2. Current use of hormonal contraception; use of any type of combined contraceptive or oral progestins within the past month; or use of hormonal implants or depo progestins within the past 3 months~3. Other known cause of infertility: endometriosis, tubal factor, uterine abnormalities~4. Uncorrected thyroid disease~5. Untreated hyperprolactinemia.~6. Medical conditions in which avoiding pregnancy is recommended until under improved control: poorly controlled Type 1 or Type 2 diabetes, poorly controlled hypertension~7. Contraindications to clomiphene citrate: hypersensitivity to CC or any of its components, history of liver disease or known liver disease, unknown cause of abnormal uterine bleeding, or intracranial lesion~8. Contraindications to letrozole: hypersensitivity to letrozole or any of its components.~9. Use of medications known to affect reproductive function or metabolism or that are an absolute contraindication during pregnancy within the past month.~10. If patients are suspected based on clinical findings for other etiologies that mimic PCOS, work up must be completed to exclude other etiologies prior to enrollment (i.e. Cushing's syndrome, androgen-secreting tumor).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Letrozole (Type: ACTIVE_COMPARATOR): Letrozole 2.5 mg orally for 5 days on cycle days 3-7
- Letrozole + Clomiphene (Type: EXPERIMENTAL): Letrozole 2.5 mg orally for 5 days on cycle days 3-7 AND Clomid 50 mg orally for 5 days on cycle days 3-7

Based on this trial design, predict the completion outcome and termination type (if applicable).